Early recognition of schizophrenia and the importance of its impact on course and outcome;Früherkennung der schizophrenie und die bedeutung für verlauf und outcome

Journal fur Neurologie, Neurochirurgie und Psychiatrie

Volumn 8, Issue 2, 2007, Pages 24-34

  Maurer, Kurt ^a   Hafner H ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Course and outcome; DUI; DUP; Early detection; Schizophrenia

Indexed keywords

AMISULPRIDE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC TEST; DISEASE COURSE; EARLY DIAGNOSIS; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HUMAN; PSYCHOSIS; QUASI EXPERIMENTAL STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT GAIN;

EID: 34249894169     PISSN: 16081587     EISSN: 16809440     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins T, Barnes T. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis. Br J Psychiatry 2002; 181 (Suppl 43): 38-44.
2. Krstev H, Carbone S, Harrigan SM, Curry C, Elkins K, McGorry PD. Early intervention in first-episode psychosis. The impact of a community development campaign. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 711-9.
3. Köhn D, Niedersteberg A, Wieneke A, Bechdolf A, Pukrop R, Ruhrmann S, Schultze-Lutter F, Maier W, Klosterkötter J. Frühverlauf schizophrener Ersterkrankungen mit langer Dauer der unbehandelten Erkrankung - eine vergleichende Studie. Fortschr Neurol Psychiatr 2004; 72: 88-92.
4. Phillips LJ, Yung AR, McGorry PD. Identification of young people at risk of psychosis: validation of the Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry 2000; 34: 164-9.
5. Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, Maier W, Bottlender R, Möller HJ, Gaebel W, Wölwer W. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254: 117-28.
6. Häfner H, Maurer K. Prodromal symptoms and early detection. In: Maj M, Lopez-Ibor JJ, Sartorius N, Sato M, Okasha A (eds). Early Detection and Management of Mental Disorders. Wiley, Chichester, 2005; 1-49.
7. Yung AR, Phillips L, McGorry P, Ward J, Donovan K, Thompson K. The comprehensive assessment of at-risk mental states (CAARMS). Melbourne: University of Melbourne, Department of Psychiatry, Australia, 2000.
8. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Marchovich PJ, Stein K, Woods SW. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002; 159: 863-5.
9. Gross G, Huber G, Klosterkötter J, Linz M. Bonner Skala für die Bestimmung von Basissymptomen (BSABS). Springer Verlag, Berlin, 1987.
10. Schultze-Lutter F, Klosterkötter J. Schizophrenia Prediction Instrument, Adult Version (SPI-A). Universität Köln, 2004.
11. Häfner H, Riecher A, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, an der Heiden W. Ein Instrument zur retrospektiven Einschätzung des Erkrankungsbeginns bei Schizophrenie (Instrument for the Retrospective Assessment of the Onset of Schizophrenia - "IRAOS"). Entwicklung und Ergebnisse. Z Klin Psychol 1990; 19: 230-55.
12. Häfner H, Löffler W, Maurer K, Riecher-Rössler A, Stein A. IRAOS: Interview für die retrospektive Erfassung des Erkrankungsbeginns und -verlaufs bei Schizophrenie und anderen Psychosen. Verlag Hans Huber, Bern, 1999.
13. Maurer K, Könnecke R, Schultze-Lutter F, Weber D, Häfner H. ERIraos: Early Recognition Inventory. Erhebungsinstrumente für das Kompetenznetz Schizophrenie (KNS PV I / TP 1.1.1), Mannheim, unveröffentlicht, 2000.
14. Maurer K, Häfner H, Hörrmann F, Schmidt M, Trendler G, Bechdolf A, Ruhrmann S, Klosterkötter J, Wagner M, Maier W, Bottlender R, Möller HJ, Wölwer W, Gaebel W. Le développement de l'inventaire de dépistage ERIraos: Un outil global d'appreciation du risque d'évolution psychotique. Psychiatrie, Sciences Humaines, Neurosciences 2005; III (Suppl 1): 29-41.
15. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-64.
16. Chapman LJ, Chapman PJ. Scales for rating psychotic or psychoticlike experiences as continua. Schizophr Bull 1980; 6: 476-89.
17. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiatr Scand 2005; 113: 273-82.
18. Gross G. Prodrome und Vorpostensyndrome schizophrener Erkrankungen. In: Huber G (Hrsg). Schizophrenie und Zyklothymie. Thieme, Stuttgart, 1969; 177-87.
19. Lindelius R. A study of schizophrenia: a clinical, prognostic and family investigation. Acta Psychiatr Scand 1970; 216 (Suppl): 1-125.
20. Huber G, Gross G, Schüttler R. Schizophrenie: Eine Verlaufs- und sozialpsychiatrische Langzeitstudie. Springer, Berlin, 1979.
21. Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DJ, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992; 149: 1183-8.
22. Beiser M, Erickson D, Flemming JAE, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349-54.
23. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22: 305-26.
24. Lewine RJ. Sex differences in age of symptom onset and first hospitalisation in schizophrenia. Am J Orthopsychiatry 1980; 50: 316-22.
25. Häfner H, Maurer K, Löffler W, Bustamante S, an der Heiden W, Riecher-Rössler A, Nowotny B. Onset and early course of schizophrenia. In: Häfner H, Gattaz WF (eds). Search for the Causes of Schizophrenia. Vol III. Springer, Berlin, 1995; 43-66.
26. Johannessen JO, Larsen TK, McGlashan T. Duration of untreated psychosis: an important target for intervention in schizophrenia? Nord J Psychiatry 1999; 53: 275-83.
27. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157: 808-15.
28. Rowlands RP. Auditing first episode psychosis: giving meaning to clinical governance. Int J Clin Pract 2001; 55: 669-72.
29. Häfner H, Maurer K, Löffler W, an der Heiden W, Stein A, Könnecke R, Hambrecht M. Onset and prodromal phase as determinants of the course. In: Gattaz WF, Häfner H (eds). Search for the Causes of Schizophrenia. Vol IV. Balance of the Century. Steinkopff, Darmstadt; Springer, Berlin, 1999; 35-58.
30. Harrigan SM, McGorry PD, Krstev H. Does delay in first-episode psychosis really matter? Psychol Med 2003; 33: 97-110.
31. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000; 177: 511-5.
32. Black K, Peters L, Rui Q, Milliken H, Whiteborn D, Kopala LC. Duration of untreated psychosis predicts outcome in an early psychosis program. Schizophrenia Res 2001; 47: 215-22.
33. Bottlender R, Sato T, Jäger M, Wegener U, Wittmann J, Strauss A, Möller HJ. The impact of the untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophrenia Res 2003; 62: 37-44.
34. McGorry PD, Yung A, Phillips L. Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophrenia Research 2001; 51: 17-29.
35. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophrenia Res 2001; 49: 231-41.
36. Warner R. Early intervention in schizophrenia: a critique. Epidemiol Psychiatr Soc 2002; 11: 248-55.
37. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophrenia Res 2000; 45: 1-9.
38. Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177: 207-11.
39. Haley CJ, Drake RJ, Bentall RP, Lewis SW. Health beliefs link to duration of untreated psychosis and attitudes to later treatment in early psychosis. Soc Psychiatry Psychiatr Epidemiol 2003; 86: 311-6.
40. de Haan L, van der Gaag M, Wolthaus J. Duration of untreated psychosis and the long term course of schizophrenia. Eur Psychiatry 2000; 15: 264-7.
41. Altamura AC, Bassetti R, Sassella F, Salvadori D, Mundo E. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophrenia Res 2001; 52: 29-36.
42. Linszen D, Dingemans P, Lenior M. Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications. Schizophrenia Res 2001; 51: 55-61.
43. Bottlender R, Sato T, Jäger M, Groll C, Strauss A, Möller HJ. The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients. Eur Arch Psychiatry Clin Neurosci 2002; 252: 226-31.
44. Malla AK, Norman RM, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia Res 2002; 54: 231-42.
45. Malla AK, Norman RM, Manchanda R, McLean TS, Harricharan R, Cortese L, Townsend LA, Scholten DJ. Status of patients with firs-tepisode psychosis after one year of phase-specific community-oriented treatment. Psychiatr Serv 2002; 53: 458-63.
46. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophrenia Res 2002; 54: 223-30.
47. de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr Bull 2003; 29: 341-8.
48. Malla AK, Norman RM, Takhar J, Manchanda R, Townsend L, Scholten D, Haricharan R. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? J Nerv Ment Dis 2004; 192: 455-63.
49. Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Gur R, Tollefson G. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004; 185: 18-24.
50. Addington J, van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004; 34: 277-84.
51. Fuchs J, Steinert T. Dauer der unbehandelten Psychose (DUP): Ein brauchbarer Prädiktor für den Krankheitsverlauf? Fortschr Neurol Psychiatr 2004; 72: 79-87.
52. Üçok A, Polat A, Genç A, Cakiotar S, Turan N. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatry Res 2004; 38: 163-8.
53. Emsley R, Turner HJ, Oosthuizen PP, Carr J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical outcome correlates. Schizophrenia Res 2005; 75: 35-44.
54. Alptekin K, Erkoc S, Gogus AK, Kultur S, Mete L, Üçok A, Yazici KM. Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up. Psychiatry Res 2005; 135: 103-11.
55. Chen EY, Hui CL, Chan RC, Dunn EL, Miao MY, Yeung WS, Wong CK, Chan WF, Tang WN. A 3-year prospective study of neurological soft signs in first episode schizophrenia. Schizophrenia Res 2005; 75: 45-54.
56. Galinska B, Szulc A, Czernikiewicz A. Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates. Psychiatria Polska 2005; 39: 859-68.
57. Gunduz-Bruce H, McMeniman M, Robinson DG, Woerner MG, Kane JM, Schooler NR, Lieberman JA. Duration of untreated psychosis and time to treatment response for delusions and hallucinations. Am J Psychiatry 2005; 162: 1666-9.
58. Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, Prasser AL, Jackson HJ, McGorry PD. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophrenia Res 2005; 79: 85-98.
59. Melle I, Friis S, Haahr U, Johannessen JO, Larsen TK, Opjordsmoen S, Roessberg JI, Rund BR, Simonsen E, Vaglum P, McGlashan T. Measuring quality of life in first-episode psychosis. Eur Psychiatry 2005; 20: 474-83.
60. Üçok A, Polat A, Çakir S, Genç A. One year outcome in first episode schizophrenia. Predictors of relapse. Eur Arch Psychiatry Clin Neurosci 2006; 256: 37-43.
61. Malla A, Norman R, Schmitz N, Manchanda R, Bechard-Evans L, Takhar J, Haricharan R. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med 2006; 36: 649-58.
62. Flyckt L, Mattson M, Edman G, Carlsson R, Cullberg J. Predicting 5-year outcome in first-episode psychosis: construction of a prognostic rating scale. J Clin Psychiatry 2006; 67: 916-24.
63. Craig TJ, Bromet EJ, Fenning S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157: 60-6.
64. Ho BC, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, Andreasen NC. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 2003; 160: 142-8.
65. Marshall M, Lockwood A. Early intervention for psychosis. Cochrane Database Syst Rev 2004; (2): CD004718.
66. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2005; 113: 247-72.
67. Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 2003; 54: 453-64.
68. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921-8.
69. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br J Psychiatry 2004; 185: 291-7.
70. Bechdolf A, Ruhrmann S, Janssen B, Bottlender R, Wagner M, Maurer K, Häfner H, Maier W, Klosterkötter J. Prävention der Schizophrenie - Früherkennung und -intervention bei Personen mit erhöhtem Psychoserisiko. Psychoneuro 2004; 30: 606-14.
71. Bechdolf A, Phillips LJ, Francey SM, Leicester S, Morrison AP, Veith V, Klosterkötter J, McGorry PD. Recent approaches to psychological interventions for people at risk for psychosis. Eur Arch Psychiatry Clin Neurosci 2006; 256: 159-73.
72. Sannomiya M, Katsu H, Nakayama K. A clinical study of emergent anxiety in neuroleptic-naive, first-episode schizophrenia patients following treatment with risperidone. Seishin Shinkeigaku Zasshi 2003; 105: 643-58.
73. Johannessen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, Mardal S, Kvehaek R, Friis S, Melle I, Opjordsmoen S, Simonsen E, Ulrik H, Vaglum P. Early detection strategies for untreated first-episode psychosis. Schizophrenia Res 2001; 51: 39-46.
74. Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand 1999; 100: 96-104.
75. Yung AR, Organ BA, Harris MG. Management of early psychosis in a generic adult mental health service. Aust N Z J Psychiatry 2003; 37: 429-36.
76. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-83.
77. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804.
78. Friis S, Larsen TK, Melle I, Opjordsmoen S, Johannessen JO, Haahr U, Simonsen E, Rund BR, Vaglum P, McGlashan T. Methodological pitfalls in early detection studies - the NAPE Lecture 2002. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr Scand 2003; 107: 3-9.
79. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001; 31: 381-400.
80. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry 1998; 172 (Suppl): 14-20.
81. Møller P. Duration of untreated psychosis: are we ignoring the mode of initial development? An extensive naturalistic case study of phenomenal continuity in first-episode schizophrenia. Psychopathology 2001; 34: 8-14.
82. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Könnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases. A controlled study of schizophrenia, depression and healthy controls. Schizophrenia Res 2005; 77: 11-24.
83. Maurer K, Trendler G, Schmidt M, an der Heiden W, Könnecke R, Häfner H. Schizophrenie und Depression. Nervenarzt 2006; 77: 809-22.